VAT of lean subjects showed an undetectable ERK1/2 activation, in contrast to the high levels of ERK 1/2 activation seen in morbid obese patients (high IR-MO and T2D-MO) compared with controls. The gene discussed is MAPK3; the disease is type 2 diabetes mellitus.